Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05205382 · ClinicalTrials.gov registry record · NA
Assessing the Effect of Nicotine Reduction on ENDS User's Addiction and Exposures
A NA study, sponsored by Florida International University.
- Completed
- Registry status
- NA
- Development phase
- 116
- Enrollment target
NCT05205382 is a NA study that has completed, run by Florida International University. The registered enrollment target is 116 participants.
The verdict
NCT05205382, a NA study, has completed, sponsored by Florida International University.
- COMPLETED
- Registry status
- NA
- Development phase
- 116 participants
- Enrollment target
Study Summary
The rapid increase of electronic nicotine delivery systems (ENDS) use by young people in the US and their potential to harm health, cause addiction, and serve as a risk for cigarette smoking or dual-use is alarming. The epidemic of ENDS use among young people in the US has been associated with the rise in popularity of ENDS products that are very efficient in delivering high doses of nicotine to users. Therefore, the investigators propose to study the effects of nicotine reduction (NR) on young ENDS users as a potential regulatory strategy to reduce the addictiveness and use of ENDS. The proposed studies are directly responsive to research priories identified by the FDA and specified in this RFA under Addiction; studying the "Impact of changes in tobacco product characteristics (e.g. nicotine formulation) on dependence". This project aims to provide an overview of this project's rationale significance divided into 1) scientific rationale and regulatory implications; 2) the need to respond to the rising trend of ENDS use among young people in the US; 3) the importance of reducing the addictiveness of ENDS; 4) the strength of our clinical and analytical lab approach for regulatory purposes; and 5) the strengths and weaknesses in the rigor of prior research about NR for ENDS.
Interventions
- OTHER 5% nicotine
- OTHER 3% nicotine
- OTHER 0% nicotine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 116 participants |
| Start Date | 2022-04-01 |
| Est. Completion | 2025-04-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05205382
The ClinicalTrials.gov registry entry for NCT05205382 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 116 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Florida International University, which has 89 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which 5% nicotine is the first listed.
NCT05205382 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05205382 about?
NCT05205382 is a clinical study titled "Assessing the Effect of Nicotine Reduction on ENDS User's Addiction and Exposures". The rapid increase of electronic nicotine delivery systems (ENDS) use by young people in the US and their potential to harm health, cause addiction, and serve as a risk for cigarette smoking or dual-use is alarming. The epidemic of ENDS use among young people in the US has been associated with the r...
What is the current status of trial NCT05205382?
This trial is currently completed. It is a NA study. The enrollment target is 116 participants. The study started on 2022-04-01. Estimated completion is 2025-04-15.
What interventions are being tested in trial NCT05205382?
The interventions under investigation include: 5% nicotine (OTHER), 3% nicotine (OTHER), 0% nicotine (OTHER).
Who is sponsoring clinical trial NCT05205382?
This trial is sponsored by Florida International University, which has 89 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.